Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05986916 · ClinicalTrials.gov registry record
Accurate Point of Care Liver Disease Diagnostics
A clinical trial of NAFLD and Nonalcoholic Fatty Liver, sponsored by University of California, San Diego.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05986916: Active study of NAFLD and Nonalcoholic Fatty Liver, sponsored by University of California, San Diego.
NCT05986916 is a study of NAFLD and Nonalcoholic Fatty Liver that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 163-participant average among 26 other NAFLD trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05986916, a study of NAFLD and Nonalcoholic Fatty Liver, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. The investigators are testing a new technology to evaluate the liver (LiverScope®), and they will compare it to other methods to evaluate the liver, including advanced conventional liver MR and liver FibroScan® ultrasound exams. MR exams and FibroScan® ultrasound exams are common exams used to monitor NAFLD. Conventional MR scanners use magnetic fields and radio waves to make pictures of the liver. LiverScope® is a small, portable MR-based device that uses similar, but simplified technology, and can be used on top of an exam table in an outpatient setting. LiverScope® currently is not approved for clinical use. In this study the investigators will learn how LiverScope® measurements of the liver compare to MR. Study participants will be asked to complete a one-time visit which includes: * LiverScope exam * MR exam * FibroScan exam (optional) * Blood draw * Completion of study questionnaires
Primary Outcome
Estimation of repeatability and reproducibility coefficients of liver PDFF values measured by LiverScope®.
Conditions Studied
Interventions
- OTHER Blood draw
- DIAGNOSTIC_TEST MR exam
- DIAGNOSTIC_TEST Liverscope® exam
- DIAGNOSTIC_TEST FibroScan® exam (optional)
- OTHER Body measurements
Study Locations (1)
California
- University of California San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-08-03 |
| Est. Completion | 2025-11 |
What the registry record for NCT05986916 still lists
NCT05986916 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 163-participant average among 26 other NAFLD trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with NAFLD appearing as the primary indexed condition, and to 5 interventions - of which Blood draw is the first listed.
NCT05986916 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05986916 about?
NCT05986916 is a clinical study titled "Accurate Point of Care Liver Disease Diagnostics". This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. The investigators are testing a new technology to evaluate the liver (LiverScope®), and they will compare it to other methods to evaluate the liver, including advanced conventional live...
What is the current status of trial NCT05986916?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2023-08-03. Estimated completion is 2025-11.
What conditions does trial NCT05986916 study?
This clinical trial studies the following conditions: NAFLD, Nonalcoholic Fatty Liver.
What interventions are being tested in trial NCT05986916?
The interventions under investigation include: Blood draw (OTHER), MR exam (DIAGNOSTIC_TEST), Liverscope® exam (DIAGNOSTIC_TEST), FibroScan® exam (optional) (DIAGNOSTIC_TEST), Body measurements (OTHER).
Who is sponsoring clinical trial NCT05986916?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05986916 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05986916's enrollment target sits among peer trials
50 19th of 26 higher than 6 of 26 other NAFLD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NAFLD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
RECRUITING
-
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
RECRUITING · Phase 2
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
Digoxin In NASH (CODIN)
RECRUITING · Phase 2
-
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
RECRUITING · Phase 3
-
Bicalutamide Therapy in Young Women With NAFLD and PCOS
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI